JANE STREET GROUP, LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,781,833
-66.7%
87,977
-57.1%
0.00%
-66.7%
Q2 2023$8,353,335
+365.0%
204,839
+325.0%
0.00%
+200.0%
Q1 2023$1,796,451
-15.6%
48,201
-21.0%
0.00%0.0%
Q4 2022$2,129,092
+23.0%
61,023
+97.3%
0.00%0.0%
Q3 2022$1,731,000
-16.5%
30,931
-22.8%
0.00%0.0%
Q2 2022$2,073,000
-84.6%
40,050
-78.3%
0.00%
-80.0%
Q1 2022$13,418,000
-31.5%
184,647
+11.5%
0.01%
-16.7%
Q4 2021$19,582,000
-15.4%
165,614
-4.0%
0.01%
-33.3%
Q3 2021$23,149,000
-75.7%
172,561
-70.7%
0.01%
-75.7%
Q2 2021$95,236,000
+475.5%
588,199
+185.3%
0.04%
+362.5%
Q1 2021$16,547,000
-6.1%
206,177
-36.4%
0.01%
-11.1%
Q4 2020$17,625,000
+2693.2%
324,011
+920.1%
0.01%
Q3 2020$631,000
-66.8%
31,762
-64.9%
0.00%
-100.0%
Q2 2020$1,902,00090,4780.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders